Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Jan 28
Show Filter
7:30am - 8:15am

Registration and Coffee

More
Showing of Streams
Showing of Streams
7:30am - 8:15am 45 mins
Registration and Coffee
8:15am - 8:30am 15 mins
Chairpersons’ Opening Remarks
  • Jeannie Joughin, PhD - Executive Vice President and Chief Commercial Officer, Enable Injections, Inc.
  • Joshua Horvath, Ph.D. - Principal Engineer, Device Development, Genentech
  • Keith Horspool, PhD - Vice President Pharmaceutics, Boehringer Ingelheim
8:30am - 9:00am 30 mins
Life cycle management through the lens of 25 years of experience
  • Avinash Thombre, PhD - Research Fellow, Pfizer
8:30am - 9:45am 75 mins
Info
20+ Hours of partneringONE® Meeting Potential in 2018

You need more time for meetings with partners, customers and clients. Last year, 400+ meetings wasn't enough, so DDP 2018 will offer more than 20+ hours of partnering time through EBD Group's partneringONE®. Leverage partneringONE® to identify and qualify technology leads and close the deal that expands your product lifecycle.

It's easy as…

  1. Request meetings. 
  2. Accept or decline requests from others.
  3. Arrive on site and meet.
9:00am - 9:45am 45 mins
Opening Panel – Marry to Market: Making the Most of Partnerships
  • Moderator Jeannie Joughin, PhD - Executive Vice President and Chief Commercial Officer, Enable Injections, Inc.
  • Panelist Alex Zuyev - Sr. Director, Injection Platforms, Sanofi
  • Panelist Mitesh Patel - Director, Lilly Research Labs at Eli Lilly and Company
9:45am - 10:15am 30 mins
Morning Refreshment Break
9:45am - 10:15am 30 mins
Morning Refreshment Break
10:00am - 10:15am 15 mins
Morning Presentation 1
10:15am - 10:45am 30 mins
Innovation in Drug Delivery
  • Uri Baruch - Head of Drug Delivery, Cambridge Design Partnerships
10:15am - 12:00pm 105 mins
20+ Hours of partneringONE® Meeting Potential in 2018
10:15am - 10:30am 15 mins
Morning Presentation 2
10:45am - 11:15am 30 mins
State of the Pharmaceutical Industry
  • Daniel Cohen - Managing Director, RBC Capital Markets LLC
11:15am - 12:00pm 45 mins
What to Expect in 2019 from the President and the Congress Relating to Health Care
  • Speaker Brent Del Monte - Senior Vice President, BGR Government Affairs
12:00pm - 1:15pm 75 mins
Networking Luncheon in the Exhibit & Poster Hall
12:00pm - 1:15pm 75 mins
Networking Luncheon in the Exhibit & Poster Hall
12:15pm - 12:30pm 15 mins
Lunch Presentation 1
12:30pm - 12:45pm 15 mins
Lunch Presentation 2
12:45pm - 1:00pm 15 mins
Lunch Presentation 3
1:15pm - 1:20pm 5 mins
Track 1: Drug Delivery Technologies
Chairperson’s Opening Remarks
  • Lionel Vedrine - A. Vice President, Head Device Research & Early Stage Development, Sanofi US
1:15pm - 1:45pm 30 mins
Info
Track 2: Strategies and Insights: Patient-Centric Design and Development Principles
Bridging User Needs & Design Requirements
  • Nick Lesniewski-Laas - Director of Electrical Engineering, Sunrise Labs

Translating user needs into formal design requirements that pass regulatory muster is a key step in medical product development.  In this session, we'll talk about how to read between the lines of user feedback, best practices for drafting design requirements, a systems approach to requirements management, and de-risking Validation through better Verification.  

1:15pm - 4:15pm 180 mins
Info
partneringONE®
partneringONE® Meetings

Leverage partneringONE® to identify and qualify technology leads and close the deal that expands your product lifecycle.

1:20pm - 1:45pm 25 mins
Track 1: Drug Delivery Technologies
Innovation in Packaging, Devices and Sensors – AstraZeneca Perspectives
  • Lubomir Gradinarsky, PhD - Science & Innovation Director, AstraZeneca
1:45pm - 2:15pm 30 mins
Track 1: Drug Delivery Technologies
Choosing the right connectivity for your drug delivery product
  • Joan Vrtis, PhD - SVP, Innovation and Technology Integration, Flex
1:45pm - 2:15pm 30 mins
Track 2: Strategies and Insights: Patient-Centric Design and Development Principles
Pfizer’s Evolving Drug Delivery Strategy: Focus on Patients
  • Advait Badkar, PhD - Sr. Director- Pharmaceutical R&D, Pfizer
2:15pm - 2:45pm 30 mins
Info
Track 1: Drug Delivery Technologies
Mechatronics for Life - The Drug Delivery Device Platform for Recombinants, Large-Volume and Combination Therapies
  • Thomas Mayer - International Sales and Application Manager, Sonceboz SA

As a Swiss technology company strongly rooted in Automotive – Platform design is at the core of Sonceboz’s DNA. For tomorrow’s drug delivery challenges we are designing and manufacturing a truly versatile device platform which builds upon a proven foundation enabling patients to perform complex injection therapies in their homes at the push of a button. The combination of WhisperDrive technology with our proprietary pump design allows for automatic reconstitution of recombinants, the sequential delivery of liquid constituents as well as the injection of highly viscous formulations. The platform utilizes cartridge and vial type containers composed of proven material combinations in order to keep stability testing at a minimum which is key to achieve fast and plannable time-to-market.


2:15pm - 2:45pm 30 mins
Track 2: Strategies and Insights: Patient-Centric Design and Development Principles
Panel: Design and Perspective on Biologics Treatments
  • Moderator Cornell Stamoran, PhD - Vice President of Corporate Strategy, Catalent Pharma Solutions
2:45pm - 3:30pm 45 mins
Track 1: Drug Delivery Technologies
Networking Refreshment Break
2:45pm - 3:30pm 45 mins
Track 2: Strategies and Insights: Patient-Centric Design and Development Principles
Networking Refreshment Break
3:00pm - 3:15pm 15 mins
New Drug Delivery Technology
Afternoon Presentation 1
3:15pm - 3:30pm 15 mins
Info
New Drug Delivery Technology
The Credence MedSystems Platform of Innovative Drug Delivery Devices: The Journey to a New Standard in Drug Delivery
3:30pm - 4:00pm 30 mins
Track 1: Drug Delivery Technologies
Injectables
  • Jeannie Joughin, PhD - Executive Vice President and Chief Commercial Officer, Enable Injections, Inc.
3:30pm - 4:00pm 30 mins
Track 2: Strategies and Insights: Patient-Centric Design and Development Principles
Patient Advocate & Patient Perspective
  • Lilly Stairs - Head of Patient Advocacy, Clara Health
4:00pm - 4:30pm 30 mins
Info
Track 1: Drug Delivery Technologies
The Creation and Use of Valuable Patents
  • John Goetz - Principal, Fish & Richardson
  • Karl Renner - Principal, Fish & Richardson P.C

Abstract:  How do you create valuable patents and use them to generate real-world marketplace value?  We will explore best practices for implementing internal company procedures—and attitudes—that lead to high-quality, commercially valuable patents and patent portfolios.  We will also discuss how to use patents either to preserve marketplace exclusivity (litigation) or to generate revenue (licensing) down the road, focusing in particular about what companies should be doing now to maximize the value of these activities later.


Key Takeaways:  

 

  • Having better technology can lead to initial success but competition eventually will come, and there will be a fight.  Companies that arm themselves by working to create valuable patents early, usually win that fight. 

  • Remember that a patent is a business tool to protect your innovations and market space, but not all patents are treated the same.  There are good patents (valuable) and bad patents (worse than worthless).   

 

  • The most successful innovative businesses believe that patents are vital to the company’s long-term health, with upper management instilling this belief into a pervasive, company-wide attitude.  A scalable in-house patent program requires educating employees, rewarding them, regular brainstorming sessions, and a patent-filing review board. 

  • While a robust patent program can be expensive, focused initial patenting efforts can add early real-world value.    

  • Thinking early about valuable patents means thinking early about litigation and licensing.  For litigation, nurture the “invention story” and improve it where you can.  Early education here is critical as well, so that communication and privilege protocols are properly understood and followed from the start.  

  • While out-licensing core technology may be neither beneficial nor desired, a strong patent program will inevitably develop tangential assets that could mature into future revenue streams.  Early thinking about valuable technology space (market gaps or competitor products) and pricing strategies will maximize revenue down the road.  


4:00pm - 4:30pm 30 mins
Track 2: Strategies and Insights: Patient-Centric Design and Development Principles
Special Population Considerations – Pediatrics & Geriatrics
4:30pm - 5:00pm 30 mins
Track 1: Drug Delivery Technologies
Case Study: Novel Technology - Patch Option for Schizophrenics
  • Ralph Lipp, Ph.D. - Vice President and Chief Scientific Officer, Noven Pharmaceuticals, Inc.
4:30pm - 5:00pm 30 mins
Track 2: Strategies and Insights: Patient-Centric Design and Development Principles
Case Study: Human Factor Design and Experience: Patient Considerations
  • Molly Story, PhD - Senior Director, Global Usability Engineering and Risk Management, Sanofi, USA
5:00pm - 6:00pm 60 mins
Track 2: Strategies and Insights: Patient-Centric Design and Development Principles
Cocktail Reception
5:00pm - 6:00pm 60 mins
partneringONE®
Cocktail Reception
5:15pm - 5:30pm 15 mins
New Drug Delivery Technology
Reception Presentation 1
5:30pm - 5:45pm 15 mins
New Drug Delivery Technology
Reception Presentation 2
5:45pm - 6:00pm 15 mins
New Drug Delivery Technology
Reception Presentation 3